Children with arthritis face elevated cancer risk

Patients aged 12 years and up with completely resected Stage IIB/C melanoma can now be treated (adjuvant) with FDA-approved nivolumab (Opdivo; Bristol Meyers Squibb Company).

An expert in pediatric hematology and oncology discusses the important role of a child’s medical home in diagnosing and treating these disorders.

Annual Walk & Roll For Wishes raises vital funds to restore hope when hope is needed most

In a recent study, ultrasound radiomics showed effective predictive ability for extrathyroidal extension (ETE) in pediatric papillary thyroid cancer (PTC).

Margaret Scarlett, DDS, and Michelle Strange, MSDH, RDH, outline how a mother's oral health can affect the oral health of her unborn child, and how teledentistry can help mothers access the care they need for themselves and their children.

The European Commission has granted an expanded approval to ravulizumab-cwvz to include children with a body weight of at least 10 kg, as well as adolescents, with paroxysmal nocturnal hemoglobinuria.